Introduction: Phthalate exposure may reduce intellectual development in young children. In 2011, numerous Taiwanese children had been reported to have consumed phthalate-tainted products. We investigated the effects of phthalate exposure on the intellectual development of these children after the 2011 Taiwan di-2-ethylhexyl phthalate (DEHP) episode. Methods: We recruited 204 children, aged 3-12 y, from 3 hospitals in Taiwan between 2012 and 2013. Firstmorning urine samples were collected for analyzing 5 phthalate metabolites. We applied a Bayesian model to estimate the past DEHP exposure ( est DEHP ADD ) of each participant before the 2011 DEHP episode. Demographic information, consumption of phthalate-tainted products, and maternal education, of each participant were obtained using a questionnaire. We used the Wechsler intelligence evaluation tools for assessing the children's and maternal intelligence quotient. Results and discussion: The median levels of mono-2-ethylhexyl phthalate, mono(2-ethyl-5-hydroxyhexyl) phthalate, mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono-n-butyl phthalate, and mono-iso-butyl phthalate in the children were 9.97, 45.8, 32.2, 46.2, and 24.3 μg/g creatinine, respectively. Using the aforementioned urinary phthalate metabolites, we found that the children's verbal comprehension index (N =98) was significantly negatively associated with urinary log 10 MEOHP (β, −11.92; SE, 5.33; 95%CI, −22.52~−1.33; P=0.028) and log 10 ΣDBP metabolites (β, −10.95; SE, 4.93; 95%CI, −20.74~−1.16; P=0.029) after adjustment for age, gender, maternal IQ and education, passive smoking, est DEHP ADD , active and passive smoking during pregnancy. Through a tolerable daily intake-based approach, we only found a significant negative association between past estimate DEHP ADD and VIQ ≥3-< 6 in preschool children whereas no correlation was observed between current DEHP exposure and IQ ≥3-< 6 score with/ without estimate DEHP ADD adjustment. It revealed that the effect of past high-DEHP exposure on verbal-related neurodevelopment of younger child are more sensitive. Conclusion: Our results are consistent with the hypothesis that exposure to DEHP and DnBP affects intellectual development in preschool and school-aged children, particularly their language learning or expression ability.
Introduction
Phthalates, such as di-2-ethylhexyl phthalate (DEHP), are widely used in many daily products in plastics, toys, and medical equipment; diethyl phthalates (DEPs) are used in cosmetics and personal care products, and di-n-butyl phthalate (DnBP) is used in food packaging films and plastic products. Humans may be exposed to phthalates mainly through the ingestion of phthalate-tainted food or inhalation and dermal absorption of phthalate-containing products. Urinary phthalate metabolites are considered suitable biomarkers for assessing the extent of exposure (Zota et al., 2014; Huang et al., 2015a Huang et al., , 2017 .
In 2011, many Taiwanese parents self-reported, in the clinic, that their children had ingested DEHP or phthalate-tainted products, including nutritional supplements, probiotics, beverages (teas, juices, and sport drinks), and jelly after the episode of DEHP exposure in 2011 (Wu et al., 2012 (Wu et al., , 2013 Huang et al., 2015a; Chang et al., 2017 ). An official investigation reported that DEHP levels in some DEHP-tainted nutritional supplements ranged between 100 and 1000 ppm (Wu et al., 2013) . However, no information is available regarding the potential long-term effects of human exposure to high-dose DEHP-tainted food products on neurodevelopment, particularly in young children.
Epidemiological studies have revealed that low-level phthalate exposure might affect neurodevelopment and behavior in children depending on their age and gender. Some studies have indicated that exposure to low doses of certain phthalates, such as of DEHP and DnBP, is associated with prenatal or postnatal neurodevelopment in children (Cho et al., 2010; Kim et al., 2011; Tellez-Rojo et al., 2013; Whyatt et al., 2012; Huang et al., 2015b) . A few studies have reported that phthalate exposure during childhood might correlate with children's behavioral development, with a possible association with autism spectrum disorder or behavioral issues (Engel et al., 2010; Larsson et al., 2009; Testa et al., 2012; Park et al., 2014 Park et al., , 2015 Kobrosly et al., 2014; Lien et al., 2015) .
Experimental studies have provided some indications regarding how phthalates might affect the brain and neurons through different mechanisms. In rats, postnatal exposure to phthalates, including DEHP and DnBP, altered dopamine receptors and transporters in the midbrain and striatum (Ishido et al., 2004; Tanida et al., 2009) . In rats and mice, prenatal exposure to DEHP and DnBP affected reference memory, spatial learning, and surface righting reflex or impaired neurodevelopment through hormone-related receptors (Dai et al., 2015; Harris et al., 2007; Smith et al., 2011; Lin et al., 2011; Xu et al., 2015) . Human and animal studies have revealed that phthalate exposure might negatively affect neurodevelopment. Thus, we evaluated the effects of phthalate exposure on the intellectual development of children exposed to phthalate-tainted products.
Methods

Participant recruitment
Study participants were recruited from among individuals who obtained consultation services provided by 128 hospitals across Taiwan and who were then transferred to specialty clinics at 3 participating hospitals after plasticizer contamination was reported in 2011 (Tsai et al., 2016a (Tsai et al., , 2016b (Tsai et al., , 2016c Chen et al., 2016) . Briefly, a total of 347 participants were recruited by the RAPIT project, including 237 children from Taipei, Taichung Hospital, run by the Ministry of Health and Welfare, and Kaohsiung Medical University Chung-Ho Memorial Hospital in northern, central, and southern Taiwan, respectively, between August 2012 and February 2013. We included 204 children (≥3 year old and < 12 year old) to evaluate their intellectual development using Wechsler tools. This research protocol was approved by the Research Ethics Committee of the National Health Research Institutes (No. EC1000903) and the collaborating hospitals. Written informed consent on behalf of the participated children was obtained from their parents after receiving written and oral information about this study.
Sample collection
We collected a 50-mL sample of first-morning urine from each participant, in a polypropylene bottle. Each sample was immediately transferred into an amber glass bottle and stored at −20°C before analysis. The samples were analyzed for assessing kidney function, such as creatinine levels. Furthermore, 5 phthalate metabolites, including mono-2-ethylhexyl phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), mono-n-butyl phthalate (MnBP), mono-iso-butyl phthalate (MiBP), were analyzed using a quantitative liquid chromatography and electrospray ionization tandem mass spectrometry (LC-ESI/MS-MS) system.
Questionnaire assessment
Information regarding demographic, socioeconomic, and other factors that could confound phthalate exposure, as well as affect the children's cognitive development was collected. We used a questionnaire to obtain information regarding individual characteristics (age, gender, residence, education of their mother, and family income), health status (childbirth, lactation), environmental exposures (active and passive cigarette smoking in children and their mother during pregnancy, and insecticide usage).
Urinary levels of phthalate metabolites
In each urine sample, 5 phthalate metabolites (MEHP, MEHHP, MEOHP, MnBP, and MiBP) that represented exposure to 3 reported phthalates (DEHP, DnBP, and DiBP) in phthalate-tainted foods were measured. We used an analytical method to assess (Huang et al. 2015a (Huang et al. , 2015b ) the levels of these metabolites. Briefly, after the urine samples were thawed and sonicated for 10-15 min, a 100-μL urine sample was loaded into a 2-mL glass vial containing ammonium acetate (20 μL), β-glucuronidase (10 μL), and a 10-isotope ( 13 C 4 ) mixture as the phthalate metabolite standard (100 μL). We used HPLC-grade H 2 O (Merck, Darmstadt, Germany) as reagent water in preparation of stock solution (like standard solution) and quality control samples (like blank sample). After the sample was incubated (37°C; 90 min), a 270-μL solution (5% acetonitrile [ACN] with 0.1% formic acid [FA] ) was added. The mixture was placed in a vortex and sealed with a PTEF cap for analysis. We used an online system coupled with a LC-ESI-MS/MS (Agilent 1200/ API4000). We used 2 columns in our online system. One of the C18 column (Inertsil ODS-3; 33 mm×4.6 mm; 5 µm) was used for extracting and cleaning the samples, whereas the other analytical column (Inertsil Ph-3; 150 mm×4.6 mm; 5 µm) was used to separate different phthalate metabolites. The gradient program for the clean-up column was as follows: 100% solution A (5% ACN +0.1% FA) (0-7 min), 100% solution B (90% ACN +0.1% FA) (7-9 min), and 100% solution A (9-10 min) that was continued for 12 min. The flow rate was set at 1000 μL/min. The gradient program for the analytical column was as follows: 100% solution C (50% ACN +0.1% FA) (0-3.6 min), 100% solution D (95% ACN +0.1% FA) (3.6-8.6 min), and 100% solution C (8.6-9 min) that was continued for 12 min. We used a negative multiple reaction mode model for MS detection. ] > 0.995), and each batch included blank, repeat, and spiked samples for quality control. We also monitored the recoveries of an isotopic 13 C 4 -labeled internal standard for each phthalate metabolite. The concentration of the blank samples P.-C. Huang et al. Environmental Research 156 (2017) 158-166 was less than 2 times the detection limit. The QC sample was spiked in a pooled urine sample with a mixture of phthalate metabolite standards (20-50 ng/mL) in each sample. The relative percent difference of repeat sample and recovery of QC sample was within ± 30%.
Estimated daily intake of DEHP before the 2011 Taiwan DEHP episode
For evaluating the potential effects of phthalate exposure in our participants before the 2011 Taiwan DEHP episode, we used a published method to estimate the daily intake of DEHP in participants before the 2011 DEHP episode. Briefly, a detailed exposure assessment questionnaire was applied, and we obtained information regarding whether the participants were exposed, the approximate exposure frequency, and possible exposure duration. Including a self-report list provided more specific detailed information regarding the product name, producer, consumption amount, frequency, and explicit duration (particularly for nutritional supplements). Therefore, we estimated the average daily intakes (AvDIs) of DEHP separately from the questionnaire (AvDI QN ) and from the selfreport list (AvDI SF ) (if provided by a participant's caregiver). Furthermore, we assumed that the lifestyle of our participants remained unchanged after the episode, and the background exposure (AvDI ENV ) was estimated by converting the urine DEHP metabolite measurements using Eq. (1). Then, we applied Bayesian models to estimate their daily DEHP exposure dose, as an estimation of exposure to DEHP-tainted food products, which has been described in detail in a previously published study . Briefly, a Bayesian statistical procedure using MCMC simulation was employed to deal with the complexity of uncertainties in the DEHP concentrations of the contaminated foods and exposure scenarios of the participants. Different prior lognormal distributions were used to describe the measured DEHP concentrations of the tainted foods, and a mixture distribution for average concentration was obtained by weighing the proportions of various product measurements for each food category. Then, we used the following Eq. (2) to obtain the individual average for the exposure period to DEHP-contaminated products (ADD DEHP ).
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Intellectual evaluation
The intellectual performance of children is a result of long-term development. All intellectual evaluations were performed by qualified and certified psychologists in the hospital on the participants by using a standardized protocol. We used the Chinese version of the Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R) (Wechsler, 2000) and the Wechsler Intelligence Scale for Childrenversion IV (WISC-IV) (Wechsler, 1997) to assess the participant's IQ at ages ≥3-< 6 y and ≥6-< 12 y, respectively. We labeled the scores IQ ≥3-< 6 , which represented the IQ score for WPPSI-R, and IQ ≥6-< 12 , which represent the IQ score for WISC-IV, to present the results obtained with different IQ evaluation tools. The WPPSI-R and WISC-III are universally acknowledged tools for evaluating the IQ of preschool children, and they also provide a thorough sampling of the abilities of children with below-average IQ scores (Lanphear et al., 2005; Huang et al., 2015b) . The WPPSI-R has 5 subtests on verbal skills (arithmetic, comprehension, information, similarities, and vocabulary) and 5 subtests on visual-spatial skills (block design, geometric design, mazes, object assembly, and picture completion). Verbal IQ ≥3-< 6 (VIQ ≥3-< 6 ), which represents combined scores for the verbal tests and performance, and IQ ≥3-< 6 (PIQ ≥3-< 6 ), which represents combined scores for the visual-spatial tests, were standardized to yield the full-scale IQ (FSIQ ≥3-< 6 ).
WISC-IV has 5 verbal comprehension index (VCI) subtests (vocabulary, similarities, comprehension, information, and word reasoning); 4 perceptual reasoning index (PRI) subtests (block design, picture concepts, matrix reasoning, and picture completion); 3 working memory index (WMI) subtests (digit span, letter-number sequencing, and arithmetic); and 3 processing speed index (PSI) subtests (coding, symbol search, and cancelation). Full-scale IQ ≥6-< 12 (FSIQ ≥6-< 12 ) was obtained by combining the VCI, PRI, WMI, and PSI scores.
We also evaluated the intelligence of the children's mothers using the Wechsler Adult Intelligence Scale-III (WAIS-III; Wechsler, 2002) for adjusting the children's cognitive development. The WAIS-III also has 3 VCI subtests (information, similarities, and vocabulary); 2 WMI subtests (arithmetic and digit span) to yield the verbal IQ m (VIQ m ); 3 perceptual organization index subtests (block design, matrix reasoning, and picture completion); and 2 PSI subtests (digit-symbol-coding, symbol search) to yield a performance IQ m (PIQ m ). Full-scale IQ m (FSIQ m ) was obtained by combining the VIQ m and PIQ m scores.
Statistical analysis
To evaluate intellectual performance using the Wechsler tools, we categorized the participants into age groups with a cut-off age of 6 y. We used the Student's t-test for examining continuous variables and the χ 2 test for analyzing categorical variables. We calculated the "not detectable (ND)" levels as half the detection limit of each phthalate metabolite, and the detectable rate as the number of urine samples with levels of each phthalate metabolite higher than the detection limit divided by all the analyzed urine samples. We calculated the sum (∑) of DEHP metabolites by using the molar concentrations of all DEHP metabolites, and ∑DBP metabolites by adding molar concentrations of MnBP and MiBP. Because the distributions of urinary phthalates were skewed in the samples, we used logarithm-transformed values in the analysis. Pearson correlation coefficients were used to assess the associations among age, gestation, IQ values, and the level of each urinary phthalate metabolite. Principal component analysis and cluster analysis were applied to assess the exposure profiles of different phthalates compared with different populations. Physiological factors or variables that significantly correlated with urinary phthalate metabolite levels were included in the multiple regression model. We also evaluated the correlation between adjusted creatinine and unadjusted phthalate metabolite levels. The associations between the urinary phthalate level and the full-scale IQ scores were assessed using a regression model after adjusting for covariates (such as age, gender, maternal IQ, maternal education, passive smoking, maternal active and passive smoking during pregnancy, and/or estimate DEHP ADD ). A 2-sided P value of < 0.05 was considered significant. All statistical analyses were conducted using SPSS (version 22.0; IBM Corp, Armonk, NY). Table 1 lists the demographic characteristics of the 204 study participants stratified by age groups, including preschool children (aged ≥3-< 6 y; N =108) and school-aged children (aged ≥6-< 12 y; N =96). The mean primary caregiver age and maternal age during pregnancy were > 37 and > 30 y, respectively. Nearly 70% of the mothers received a college education, > 92% of the participants were breastfed, < 5% of the participants' mothers were active smokers and consumed alcohol, and approximately 20% of the participants' mothers were exposed to second-hand smoke during pregnancy. Table 2 present the levels of the 5 phthalate metabolites in the urine samples collected from the participants (N =204) between the groups. Median levels for most of the phthalate metabolites were higher in preschool children than in school-aged children. Table 2 also lists the estimated daily dose (ADD est ) of DEHP for our participants before the 2011 DEHP episode. We observed that the median (range) ADD est levels for DEHP were 15.1 (0.6-140.0) μg/kg/day for preschool children and 12.2 (2.8-88.5) μg/kg/day for school-aged children. Table 3 lists the WPPSI-R (N =108), WISC-IV (N =96), and WAIS-III scores for our participants stratified by gender. The FSIQ ≥3-< 6 scores for most preschool children and school-aged children were within the normal range, regardless of gender. We found that girls had significantly higher WISC-IV scores than did the boys for WMI ≥6-< 12 (114 vs 107, respectively; P=0.021) and PSI ≥6-< 12 (105 vs 98, respectively; P=0.024). Girls had higher PIQ ≥3-< 6 scores than did boys (111 vs 105, respectively; P=0.051). However, we did not observe a significant Abbreviations: MEHP = mono-2-ethylhexyl phthalate; MEOHP = mono-(2-ethyl-5-oxohexyl) phthalate; MEHHP = mono-(2-ethyl-5-hydroxylhexyl) phthalate; MnBP = mono-n-butyl phthalate; MiBP = mono-iso-butyl phthalate; ΣDEHP metabolites = MEHP + MEOHP + MEHHP; ΣDBP = MnBP + MiBP. a Estimate DEHP exposure before 2011 Taiwan DEHP food scandal. b Preschool children: children aged ≥3-< 6 y; School-aged children: child aged ≥6-< 12 y.
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P.-C. Huang et al. Environmental Research 156 (2017) 158-166 difference among the VIQ ≥3-< 6 , VCI ≥6-< 12 , PRI ≥6-< 12 , or in the maternal FSIQ (WAIS-III) scores for the participants regardless of gender.
Association between urinary phthalate metabolites and pediatric intellectual development
We assessed the relationship between urinary phthalate metabolites and IQ scores and other covariates using Pearson correlation analysis (Supplementary Table 1 ). Table 4 and Table 5 present the multiple regression results for DEHP exposure in terms of the IQ scores (WPPSI-R) of the preschool children (N =108). Among all models for the DEHP exposure estimation, we did not observe any significant difference between current exposure to DEHP and DBP and the IQ scores of the preschool children's (including FSIQ ≥3-< 6 , PIQ ≥3-< 6 , and VIQ ≥3-< 6 ) after adjustment for covariates (such as estimated DEHP ADD and maternal FSIQ). Table 5 and Fig. 1 illustrate the multiple regression results for DEHP exposure regarding the IQ ≥6-< 12 scores (WISC-IV) for the school-aged children (N =96). We found only a marginally significant correlation between urinary MEOHP and FSIQ ≥6-< 12 (β/SE, −7.4/4.1; 95%CI, −15.55 to 0.75; P=0.074) in the crude model. We found that the children's VCI ≥6-< 12 was negatively significantly associated with urinary MEOHP (β/SE, −11.92/5.33; 95%CI, −22.52 to −1.33; P=0.028), urinary MnBP (β/SE, −11.32/5.31; 95%CI, −21.89 to −0.76; P=0.036), and urinary MiBP (β/SE, -8.85/ 4.08; 95%CI, -16.96 to -0.74; P=0.033) after adjustment for the participants' age, gender, maternal IQ and education, estimate DEHP ADD , passive smoking, maternal active and passive smoking during pregnancy. However, we did not observe any significant difference between current DEHP exposure and the children's IQ scores, including FSIQ ≥6-< 12 , PRI ≥6-< 12 , WMI ≥6-< 12 , and PSI ≥6-< 12 , after adjustment for covariates. We also observed a marginal yet negative correlation between urinary MEOHP and WMI ≥6-< 12 (β/SE, −9.27/5.04; 95%CI, −19.28 to 0.75; P=0.066), whereas 2 factors exhibited significant effects (DEHP ADD : β, 11.0; P=0.031; gender: β, −6.6; P=0.013) after adjustment for the same factor. However, we did not observe similar phenomena in models for urinary MnBP or MiBP. We did not observe any correlations between any other urinary phthalate metabolites and FSIQ ≥6-< 12 or any other sub-IQ indices such as PRI ≥6-< 12 and PSI ≥6-< 12 in our participants. P.-C. Huang et al. Environmental Research 156 (2017) 158-166 Table 5 Multiple regression results for DEHP and DBP exposure regarding the WISC-IV scores for school-aged children aged ≥6-< 12 y (N =96). Abbreviations are listed in the footnote below Table 2 and Table 3 . * P < 0.05. a Model 1: Multiple regression for crude model; b Model 2: Multiple regression after adjustment for age, gender, estimate DEHP ADD , maternal IQ (WAIS-III) and education, passive smoking, maternal active smoking (during pregnancy) and passive smoking (during pregnancy). Fig. 1 . Regression coefficients (95% confidence intervals) for change in VCI ≥6-< 12 scores associated with quartiles of urinary levels of MEOHP, MnBP, and MiBP. All models were adjusted for age, gender, estimate DEHP ADD , maternal IQ (WAIS-III) and education, passive smoking, maternal active and passive smoking (during pregnancy).
WISC-IV
Discussion
We found that the current exposure to DEHP, DnBP, and DiBP for school-aged children aged ≥6-< 12 y, who were exposed to phthalatetainted products, was significantly and negatively associated with the VCI ≥6-< 12 performance after adjustment for significant covariates. Maternal IQ was slightly positively and significantly associated with the neurodevelopment for our participants aged ≥3-< 12 y. Our data revealed that the current exposure to DEHP and DBP might affect the children's nervous system that might become visible in their language learning or expression ability.
A high detection rate of DEHP, DnBP, and DiBP metabolites indicated that our participants continued to have exposure to these phthalates after the 2011 Taiwan DEHP episode. We only found a negative association between VCI ≥6-< 12 and the urinary MEOHP, MnBP, and MiBP levels in school-aged children aged ≥6-< 12 y. We found that their current DEHP or DBP metabolite exposure levels remained higher than those of the general Taiwanese pediatric population (Huang et al., 2015a) . One possible explanation is that the participants in our study may still be continuously exposed to certain products that have low-dose DEHP and DBP levels.
Three possible mechanisms may underlie the effects of phthalates on children's neurodevelopment. Phthalates may interrupt the neurotransmitter system during neuronal development. Some studies have revealed that a low-dose phthalate exposure could reduce the number of midbrain dopaminergic neurons (Tanida et al., 2009) , tyrosine hydroxylase immunoreactivity, and biosynthetic activity (Ishido et al., 2004) in rodents. Second, phthalates may indirectly affect cognitive development through the alteration of thyroid hormones by interacting with hormone synthesis proteins, deiodinases, and receptors (Breous et al., 2005; Sugiyama et al., 2005; Shen et al., 2011; Liu et al., 2015; Ye et la., 2017) . Maternal or neonatal hypothyroidism and subclinical hypothyroidism permanently affect children's cognition (de Escobar et al., 2004a (de Escobar et al., , 2004b Ohara et al., 2004) . Some studies have revealed that a low-dose phthalate exposure was associated with altered thyroid activity in children (Boas et al., 2010) , pregnant women (Huang et al., 2007 , adolescents, and adults (Meeker and Ferguson, 2011; Huang et al., 2017) . Third, peroxisome proliferator activated receptors (PPARs) are found during the development of neural tubes, and they play a role in cellular proliferation (Braissant and Wahli, 1998; Kota et al., 2005) . Phthalates may activate the PPARs (Roberts et al., 1997) by altering signal transduction during the neurodegenerative process. However, little is known about the effects of a high-dose phthalate exposure on neurodevelopment through the aforementioned mechanisms.
We only found a significant negative association between estimate DEHP ADD (past exposure) and VIQ ≥3-< 6 in preschool children, but not for other IQ index at ≥3-< 6 y or ≥6-< 12 y in this study (Supplementary Table 2 ). We did not observe significant correlations between current DEHP or DBP exposure and IQ score in our subject aged ≥3-< 6 y adjustment for other covariates and with or without estimate DEHP ADD (Supplementary Table 3 ). It indicated that the effect of past high-DEHP exposure on verbal-related neurodevelopment of younger child are more sensitive than other age groups. Most toxicological studies on DEHP or phthalates have focused on liver toxicity, reproductive, and endocrinologic effects in rodents or in vitro, whereas only a few have studied the neurological effects of DEHP or phthalates. Fetal or neonatal exposure to low-dose DEHP levels resulted in an irreversible change in the midbrain dopaminergic nuclei of mice (Tanida et al., 2009) . One animal study showed that DBP induced neurotoxicity in the brain of immature and mature rat offspring. Perinatal DBP exposure could induce neurotoxicity in immature offspring rats by regulating ER-β, BDNF, and p-CREB expression, whereas it did not influence mature offspring animals (Li et al., 2014) . Therefore, DEHP or phthalate toxicity was likely organ dependent and further studies on the association between phthalate exposure and neurodevelopment are required.
We found that current DEHP, DnBP, and DiBP exposure in schoolaged children aged ≥6-< 12 y, who were exposed to phthalate-tainted products was significantly and negatively associated with VCI ≥6-< 12 performance after adjustment for significant covariates. Our findings were consistent with those of some cross-sectional studies. One crosssectional study reported that FSIQ and VIQ scores (WISC-III) were negatively associated with DEHP metabolites in 667 elementary school-aged Korean children. A significant negative relationship existed between urinary DEHP and DBP metabolite levels and the children's vocabulary subscores after controlling for maternal IQ (Cho et al., 2010) . Another study revealed that postnatal phthalate exposure was associated with reduced cognitive development in young children in central Taiwan (Huang et al. 2015b ).
However, some prospective studies have reported the effects of prenatal phthalate exposure. One prospective study revealed that prenatal maternal urinary DnBP and DiBP metabolite levels during late pregnancy were associated with deficits in the intellectual development of children at age 7 y, particularly perceptual reasoning, working memory, processing speed, and verbal comprehension (DiBP only) (Factor-Litvak et al., 2014) . Ejaredar et al. conducted a systematic review of 11 medical articles regarding phthalate exposure on children's neurodevelopment and concluded that prenatal phthalate exposure is associated with adverse cognitive and behavior function in children (Ejaredar et al., 2015) . Because of a lack of information regarding prenatal phthalate exposure for our subjects, we could not evaluate the effect of prenatal phthalate exposure in our results.
We included several confounders in our evaluation of children's neurodevelopment that are comparable to those of other studies (Ejaredar et al., 2015) . The ages of the child and mother, gender, maternal IQ and education level, and socioeconomic status were the most frequently adjusted confounders in previous and different epidemiological studies. We included additional factors such as the active and passive smoking (during pregnancy) to assess the prenatal exposure of tobacco smoke. We also conducted an additional model to evaluate the effect of annual family income (Supplementary Table 2 and 3). We did not include breastfeeding in our model because > 90% of our participants were breastfed.
The current study had some strengths. First, we included some crucial confounders such as maternal IQ and controlled for them in our models. Second, we used a Bayesian model to estimate DEHP exposure in our participants prior to the episode of DEHP exposure and controlled it in our model. It provided an estimate of the magnitude of DEHP exposure, instead of a categorical variable. Some limitations regarding data interpretation existed in this study. First, we only have around one hundred subjects in each age group for which small sample size may limit our statistic power and interpretation. Second, the study was designed as a cross-sectional study that limited the uncertainty of causality. Third, we used only one first-morning urine sample. Variations in urinary phthalate metabolite levels in our participants were not assessed. Fourth, because of the regulations governing studies on human volunteers in Taiwan, we could not collect any specimens such as a urine or blood sample immediately after the 2011 DEHP exposure episode. Therefore, we did not have the actual data on phthalate exposure levels or duration of exposure before the DEHP episode. Fifth, we did not have any information regarding prenatal or postnatal phthalate exposure of our participants before 2011. Sixth, all the effects of multiple factors on child neurodevelopment may not have been included in the current study. Although we included some critical factors, such as maternal IQ, cigarette smoking and maternal education, we did not evaluate the effects of exposure to heavy metals or any other organic environmental pollutants.
Conclusion
Our results are consistent with the hypothesis that exposure to phthalates influences neurodevelopment in school-aged children.
Further studies are warranted to follow-up the long-term effects of phthalate exposure on neurodevelopment, such as attention deficit hyperactivity disorder, in children exposed to numerous phthalatetainted products.
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